We've found
7,522
archived clinical trials in
Chronic Pain
We've found
7,522
archived clinical trials in
Chronic Pain
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
Updated: 12/31/1969
A Study to Assess the Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and Opioid-Induced Constipation
Status: Enrolling
Updated: 12/31/1969
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
Updated: 12/31/1969
A Study to Assess the Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and Opioid-Induced Constipation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
Updated: 12/31/1969
A Study to Assess the Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and Opioid-Induced Constipation
Status: Enrolling
Updated: 12/31/1969
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
Updated: 12/31/1969
A Study to Assess the Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and Opioid-Induced Constipation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
Updated: 12/31/1969
A Study to Assess the Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and Opioid-Induced Constipation
Status: Enrolling
Updated: 12/31/1969
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
Updated: 12/31/1969
A Study to Assess the Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and Opioid-Induced Constipation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pain Study to See if Ultram ER Will Provide Relief to Subjects Whose Pain is Not Well Controlled by Narcotics
Updated: 12/31/1969
Pain Study to See if Ultram ER Will Provide Relief to Subjects Whose Pain is Not Well Controlled by Narcotics
Status: Enrolling
Updated: 12/31/1969
Pain Study to See if Ultram ER Will Provide Relief to Subjects Whose Pain is Not Well Controlled by Narcotics
Updated: 12/31/1969
Pain Study to See if Ultram ER Will Provide Relief to Subjects Whose Pain is Not Well Controlled by Narcotics
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Characterization of the Analgesic Effect of CBD in Healthy, Normal Volunteers
Updated: 12/31/1969
Characterization of the Analgesic Effects of Oral CBD in Healthy, Normal Volunteers
Status: Enrolling
Updated: 12/31/1969
Characterization of the Analgesic Effect of CBD in Healthy, Normal Volunteers
Updated: 12/31/1969
Characterization of the Analgesic Effects of Oral CBD in Healthy, Normal Volunteers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Digital Tools for Coping With Chronic Pain
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Digital Tools for Coping With Chronic Pain
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Digital Tools for Coping With Chronic Pain
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Digital Tools for Coping With Chronic Pain
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Digital Tools for Coping With Chronic Pain
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Digital Tools for Coping With Chronic Pain
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Digital Tools for Coping With Chronic Pain
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Digital Tools for Coping With Chronic Pain
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Digital Tools for Coping With Chronic Pain
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Digital Tools for Coping With Chronic Pain
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Digital Tools for Coping With Chronic Pain
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Digital Tools for Coping With Chronic Pain
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Updated: 12/31/1969
Digital Tools for Coping With Chronic Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Multisensory Integration and Pain Perception
Updated: 12/31/1969
Multisensory Integration and Pain Perception
Status: Enrolling
Updated: 12/31/1969
Multisensory Integration and Pain Perception
Updated: 12/31/1969
Multisensory Integration and Pain Perception
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract
Updated: 12/31/1969
Clinical Study Evaluating Safety and Efficacy of a Nepafenac Punctal Plug Delivery System (N-PPDS) Compared With Placebo Punctal Plug Delivery System (p-PPDS) in Controlling Post-Operative Ocular Pain and Inflammation After Routine Unilateral Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract
Updated: 12/31/1969
Clinical Study Evaluating Safety and Efficacy of a Nepafenac Punctal Plug Delivery System (N-PPDS) Compared With Placebo Punctal Plug Delivery System (p-PPDS) in Controlling Post-Operative Ocular Pain and Inflammation After Routine Unilateral Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract
Updated: 12/31/1969
Clinical Study Evaluating Safety and Efficacy of a Nepafenac Punctal Plug Delivery System (N-PPDS) Compared With Placebo Punctal Plug Delivery System (p-PPDS) in Controlling Post-Operative Ocular Pain and Inflammation After Routine Unilateral Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract
Updated: 12/31/1969
Clinical Study Evaluating Safety and Efficacy of a Nepafenac Punctal Plug Delivery System (N-PPDS) Compared With Placebo Punctal Plug Delivery System (p-PPDS) in Controlling Post-Operative Ocular Pain and Inflammation After Routine Unilateral Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract
Updated: 12/31/1969
Clinical Study Evaluating Safety and Efficacy of a Nepafenac Punctal Plug Delivery System (N-PPDS) Compared With Placebo Punctal Plug Delivery System (p-PPDS) in Controlling Post-Operative Ocular Pain and Inflammation After Routine Unilateral Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract
Updated: 12/31/1969
Clinical Study Evaluating Safety and Efficacy of a Nepafenac Punctal Plug Delivery System (N-PPDS) Compared With Placebo Punctal Plug Delivery System (p-PPDS) in Controlling Post-Operative Ocular Pain and Inflammation After Routine Unilateral Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Comparing Intravenous Hydromorphone to Usual Care
Updated: 12/31/1969
Randomized Clinical Trial Comparing Intravenous Hydromorphone to Usual Care
Status: Enrolling
Updated: 12/31/1969
Comparing Intravenous Hydromorphone to Usual Care
Updated: 12/31/1969
Randomized Clinical Trial Comparing Intravenous Hydromorphone to Usual Care
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Lidocaine-Prilocaine Cream in Conjunction With Paracervical Block for Pain With Abortion
Updated: 12/31/1969
Lidocaine-Prilocaine Cream in Conjunction With Lidocaine Paracervical Block for Pain With First-Trimester Abortion: A Double-Blind Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Lidocaine-Prilocaine Cream in Conjunction With Paracervical Block for Pain With Abortion
Updated: 12/31/1969
Lidocaine-Prilocaine Cream in Conjunction With Lidocaine Paracervical Block for Pain With First-Trimester Abortion: A Double-Blind Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Postoperative Analgesia Investigation
Updated: 12/31/1969
A Prospective Randomized-controlled Study on Effectiveness of Extended-release Liposomal Bupivacaine in Postoperative Pain Control.
Status: Enrolling
Updated: 12/31/1969
Postoperative Analgesia Investigation
Updated: 12/31/1969
A Prospective Randomized-controlled Study on Effectiveness of Extended-release Liposomal Bupivacaine in Postoperative Pain Control.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Modafinil in Opioid Induced Sedation
Updated: 12/31/1969
A Randomized Double-Blinded, Placebo Controlled, Crossover Trial Examining the Effectiveness of Modafinil in Opioid Induced Sedation
Status: Enrolling
Updated: 12/31/1969
Modafinil in Opioid Induced Sedation
Updated: 12/31/1969
A Randomized Double-Blinded, Placebo Controlled, Crossover Trial Examining the Effectiveness of Modafinil in Opioid Induced Sedation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effects of Tai Chi on Multisite Pain and Brain Functions in Older Adults
Updated: 12/31/1969
Effects of Tai Chi on Multisite Pain and Brain Functions in Older Adults
Status: Enrolling
Updated: 12/31/1969
Effects of Tai Chi on Multisite Pain and Brain Functions in Older Adults
Updated: 12/31/1969
Effects of Tai Chi on Multisite Pain and Brain Functions in Older Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pre-emptive Analgesics in Orthodontic Treatment
Updated: 12/31/1969
Effects of Pre-emptive Use of Combined Ibuprofen and Acetaminophen on Pain Control in Orthodontic Treatment
Status: Enrolling
Updated: 12/31/1969
Pre-emptive Analgesics in Orthodontic Treatment
Updated: 12/31/1969
Effects of Pre-emptive Use of Combined Ibuprofen and Acetaminophen on Pain Control in Orthodontic Treatment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of Conventional and Long Pulse Widths During a Temporary Spinal Cord Stimulation Trial
Updated: 12/31/1969
Evaluation of Clinical Outcomes of Pulse Widths <500 µS And >1000 µS During a Temporary Spinal Cord Stimulation Trial
Status: Enrolling
Updated: 12/31/1969
Evaluation of Conventional and Long Pulse Widths During a Temporary Spinal Cord Stimulation Trial
Updated: 12/31/1969
Evaluation of Clinical Outcomes of Pulse Widths <500 µS And >1000 µS During a Temporary Spinal Cord Stimulation Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase 2 Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1, CGS-200-5, and CGS-200-0
Updated: 12/31/1969
A Phase 2 Double-Blind Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1 (1% Capsaicin Topical Liquid), CGS-200-5 (5% Capsaicin Topical Liquid), and CGS-200-0 (Vehicle, No Capsaicin)
Status: Enrolling
Updated: 12/31/1969
A Phase 2 Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1, CGS-200-5, and CGS-200-0
Updated: 12/31/1969
A Phase 2 Double-Blind Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1 (1% Capsaicin Topical Liquid), CGS-200-5 (5% Capsaicin Topical Liquid), and CGS-200-0 (Vehicle, No Capsaicin)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase 2 Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1, CGS-200-5, and CGS-200-0
Updated: 12/31/1969
A Phase 2 Double-Blind Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1 (1% Capsaicin Topical Liquid), CGS-200-5 (5% Capsaicin Topical Liquid), and CGS-200-0 (Vehicle, No Capsaicin)
Status: Enrolling
Updated: 12/31/1969
A Phase 2 Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1, CGS-200-5, and CGS-200-0
Updated: 12/31/1969
A Phase 2 Double-Blind Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1 (1% Capsaicin Topical Liquid), CGS-200-5 (5% Capsaicin Topical Liquid), and CGS-200-0 (Vehicle, No Capsaicin)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase 2 Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1, CGS-200-5, and CGS-200-0
Updated: 12/31/1969
A Phase 2 Double-Blind Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1 (1% Capsaicin Topical Liquid), CGS-200-5 (5% Capsaicin Topical Liquid), and CGS-200-0 (Vehicle, No Capsaicin)
Status: Enrolling
Updated: 12/31/1969
A Phase 2 Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1, CGS-200-5, and CGS-200-0
Updated: 12/31/1969
A Phase 2 Double-Blind Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1 (1% Capsaicin Topical Liquid), CGS-200-5 (5% Capsaicin Topical Liquid), and CGS-200-0 (Vehicle, No Capsaicin)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase 2 Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1, CGS-200-5, and CGS-200-0
Updated: 12/31/1969
A Phase 2 Double-Blind Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1 (1% Capsaicin Topical Liquid), CGS-200-5 (5% Capsaicin Topical Liquid), and CGS-200-0 (Vehicle, No Capsaicin)
Status: Enrolling
Updated: 12/31/1969
A Phase 2 Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1, CGS-200-5, and CGS-200-0
Updated: 12/31/1969
A Phase 2 Double-Blind Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1 (1% Capsaicin Topical Liquid), CGS-200-5 (5% Capsaicin Topical Liquid), and CGS-200-0 (Vehicle, No Capsaicin)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase 2 Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1, CGS-200-5, and CGS-200-0
Updated: 12/31/1969
A Phase 2 Double-Blind Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1 (1% Capsaicin Topical Liquid), CGS-200-5 (5% Capsaicin Topical Liquid), and CGS-200-0 (Vehicle, No Capsaicin)
Status: Enrolling
Updated: 12/31/1969
A Phase 2 Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1, CGS-200-5, and CGS-200-0
Updated: 12/31/1969
A Phase 2 Double-Blind Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1 (1% Capsaicin Topical Liquid), CGS-200-5 (5% Capsaicin Topical Liquid), and CGS-200-0 (Vehicle, No Capsaicin)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase 2 Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1, CGS-200-5, and CGS-200-0
Updated: 12/31/1969
A Phase 2 Double-Blind Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1 (1% Capsaicin Topical Liquid), CGS-200-5 (5% Capsaicin Topical Liquid), and CGS-200-0 (Vehicle, No Capsaicin)
Status: Enrolling
Updated: 12/31/1969
A Phase 2 Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1, CGS-200-5, and CGS-200-0
Updated: 12/31/1969
A Phase 2 Double-Blind Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1 (1% Capsaicin Topical Liquid), CGS-200-5 (5% Capsaicin Topical Liquid), and CGS-200-0 (Vehicle, No Capsaicin)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Utilization of Oral Sucrose to Decrease Pain in Infants During Immunizations
Updated: 12/31/1969
Efficacy of Oral Sucrose Analgesia During Routine Immunizations at 6 Weeks and 4 Months of Age
Status: Enrolling
Updated: 12/31/1969
Utilization of Oral Sucrose to Decrease Pain in Infants During Immunizations
Updated: 12/31/1969
Efficacy of Oral Sucrose Analgesia During Routine Immunizations at 6 Weeks and 4 Months of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Patients' Perspectives About a Pain Education Video
Updated: 12/31/1969
Patients' Perspectives About a Pain Education Video
Status: Enrolling
Updated: 12/31/1969
Patients' Perspectives About a Pain Education Video
Updated: 12/31/1969
Patients' Perspectives About a Pain Education Video
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Updated: 12/31/1969
A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Efficacy and Safety of AQX-1125 (200 mg) in Male Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials